Bioorganic and Medicinal Chemistry Letters p. 3150 - 3155 (2006)
Update date:2022-08-04
Topics:
Zhu, Gui-Dong
Gong, Jianchun
Claiborne, Akiyo
Woods, Keith W.
Gandhi, Viraj B.
Thomas, Sheela
Luo, Yan
Liu, Xuesong
Shi, Yan
Guan, Ran
Magnone, Shayna R.
Klinghofer, Vered
Johnson, Eric F.
Bouska, Jennifer
Shoemaker, Alexander
Oleksijew, Anatol
Stoll, Vincent S.
Jong, Ron De
Oltersdorf, Tilman
Li, Qun
Rosenberg, Saul H.
Giranda, Vincent L.
The structure-activity relationships of a series of isoquinoline-pyridine-based protein kinase B/Akt antagonists have been investigated in an effort to improve the major short-comings of the lead compound 3, including poor pharmacokinetic profiles in several species (e.g., mouse iv t1/2 = 0.3 h, po F = 0%). Chlorination at C-1 position of the isoquinoline improved its pharmacokinetic property in mice (iv t1/2 = 5.0 h, po F = 51%) but resulted in >500-fold drop in potency. In a mouse MiaPaCa-2 xenograft model, an amino analog 10y significantly slowed the tumor growth, however was accompanied by toxicity.
View MoreChengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Sichuan Mianzhu Ronghong Chemical Co.,LTd
Contact:8613981840544
Address:XINSHI INDUSTRY PARK,MIANZHU,SICHUAN,CHINA
Tai zhou world Pharm & Chem Co., Ltd
Contact:+86-576-85301198
Address:Rome 1001,wangjiang plaza,unti 2,jinshan east Road linhai,zhejiang,china
Zhejiang PRIMAR Import & Export Trade Co., Ltd.
Contact:86-570-3630818
Address:No.1Puzhuyuan,Quhua,Zhejiang Province,China324004
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Doi:10.3390/molecules15042631
(2010)Doi:10.1002/jps.2600550108
(1966)Doi:10.1080/00397919908085933
(1999)Doi:10.1002/hlca.19600430136
(1960)Doi:10.1135/cccc19741596
(1974)Doi:10.1021/jo1025783
(2011)